DalsnaFinance Account

Medline $MDLN

Health Care

Russell 1000 Illinois

Create a scorecard

$34.88

-0.43 (-1.22%)

As of Oct 22, 2026, 9:30 PM EDT · cached

Price history

Loading chart…

Medline (MDLN) is trading down at $34.88 (-1.22%), as of the latest quote. It is a Russell 1000 constituent in the Health Care sector.

IPO: December 17, 2025 · $29.00 offering · NASDAQ · View IPO details →

Medline revenue & net income history (FY2023–FY2025)

RevenueNet incomeNet margin (right axis, %)

Medline annual financial statements
	FY2023Dec 2023	FY2024Dec 2024	FY2025Dec 2025
Income statement
Revenue	$23.2B	$25.5B	$28.4B
Growth (year over year)	—	+9.8%	+11.5%
Gross profit	$5.88B	$6.98B	$7.52B
Gross margin	25.3%	27.3%	26.4%
Operating income	$1.25B	$2.15B	$2.21B
Operating margin	5.4%	8.4%	7.8%
Net income	$234.0M	$1.16B	$1.16B
Net margin	1.0%	4.6%	4.1%
EPS (diluted)	—	—	−$0.01
Balance sheet
Cash and equivalents	$1.58B	$199.0M	$1.94B
Total assets	—	$36.0B	$38.5B
Total liabilities	—	$19.5B	$19.2B
Long-term debt	—	$16.4B	$12.5B
Shareholders' equity	—	—	$10.7B
Cash flow
Operating cash flow	$1.69B	$1.77B	$1.74B
Capital expenditure	$275.0M	$354.0M	$447.0M
Free cash flow	$1.41B	$1.42B	$1.30B
Share buybacks	$0	$20.0M	$33.0M

RevenueNet incomeNet margin (right axis, %)

Medline quarterly financial statements
	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Income statement
Revenue	$6.64B	$6.89B	—	$7.35B	$7.68B
Growth (year over year)	—	—	—	+10.7%	+11.6%
Gross profit	$1.82B	$1.91B	—	$1.84B	$2.21B
Gross margin	27.5%	27.7%	—	25.0%	28.8%
Operating income	$571.0M	$642.0M	—	$422.0M	$395.0M
Operating margin	8.6%	9.3%	—	5.7%	5.1%
Net income	$319.0M	$329.0M	—	$132.0M	$59.0M
Net margin	4.8%	4.8%	—	1.8%	0.8%
EPS (diluted)	—	—	—	$0.16	$0.07
Balance sheet
Cash and equivalents	$840.0M	$584.0M	$1.94B	$2.24B	$2.33B
Total assets	—	—	$38.5B	$39.0B	$39.4B
Total liabilities	—	—	$19.2B	$19.7B	$20.3B
Long-term debt	—	—	$12.5B	$12.5B	$12.5B
Shareholders' equity	—	—	$10.7B	$11.3B	$11.6B
Cash flow
Operating cash flow	$682.0M	$197.0M	—	$412.0M	$715.0M
Capital expenditure	$98.0M	$110.0M	—	$96.0M	$111.0M
Free cash flow	$584.0M	$87.0M	—	$316.0M	$604.0M
Share buybacks	$9.00M	$6.00M	—	$0	$0

From Medline's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. Filings on SEC EDGAR →

About Medline

Medline Inc. is an American public healthcare company headquartered in Northfield, Illinois. In June 2021 it was acquired by a consortium of private equity firms Blackstone, Carlyle and Hellman & Friedman valuing the company at US$34 billion in one of the largest leveraged buyouts of all time. It was the nation's largest privately held manufacturer and distributor of medical supplies providing products, education, clinical programs and services across the continuum of care with operations in over 125 countries and territories.

Source: Wikipedia — Medline Inc.